C. B. Almeida, E. F. Souza, e G. G. Oliveira, “Use of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia (CML)”, Sci. Electronic Arch, vol. 9, nº 5, p. 131–146, nov. 2016.